PHS
MRK icon

PFM Health Sciences’s Merck MRK Stock Holding History

PFM Health Sciences’s Portfolio MRK Stock Details MRK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-871,500
Closed -$96.7M – 96
2022
Q4 		$96.7M Buy
+871,500
New +$89.1M 3.46% 4
2020
Q4 		– Sell
-356,320
Closed -$28.2M – 94
2020
Q3 		$28.2M Buy
+356,320
New +$27.9M 1.3% 27
2015
Q1 		– Sell
-3,674,183
Closed -$332K – 93
2014
Q4 		$332K Buy
3,674,183
+2,717,673
+284% +$151M 0.01% 87
2014
Q3 		$917K Buy
+956,510
New +$53.7M 0.02% 62
2013
Q4 		– Sell
-480,718
Closed -$101K – 68
2013
Q3 		$101K Sell
480,718
-150,283
-24% -$6.86M ﹤0.01% 71
2013
Q2 		$506K Buy
+631,001
New +$28.2M 0.01% 71

Other funds holding MRK

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

PFM Health Sciences's MRK Position: Q1 2026 in Review

PFM Health Sciences sold out of Merck (MRK) in Q1 2026, closing a stake of 187,834 shares — an estimated $19.8M sold.

PFM Health Sciences first reported a position in MRK in Q2 2013 and held it in 17 quarters. The position peaked at $88.6M in Q2 2022. 3,778 funds tracked by Wall St. Rank hold MRK as of Q1 2026.

  • PFM Health Sciences reported no remaining Merck position as of Q1 2026 after selling out during the quarter.
  • PFM Health Sciences sold 187,834 Merck shares in Q1 2026, an estimated $19.8M.
  • PFM Health Sciences first reported a position in Merck in Q2 2013 and held it in 17 quarters.
  • PFM Health Sciences's Merck position peaked at $88.6M in Q2 2022.
  • 3,778 funds tracked by Wall St. Rank held Merck as of Q1 2026.

Based on PFM Health Sciences's 13F filing for Q1 2026, filed 15 May 2026.